|
Report No. : |
355375 |
|
Report Date : |
16.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
OISHI KOSEIDO CO LTD |
|
|
|
|
Registered Office : |
1-933 Honmachi Tosu City Saga-Pref 841-0037 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.08.2014 |
|
|
|
|
Date of Incorporation : |
March 1950 |
|
|
|
|
Com. Reg. No.: |
3000-01-006138 (Saga-Tosu) |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Manufactures pharmaceuticals, poultice as a main, other (--100%) |
|
|
|
|
No. of Employee : |
160 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
OISHI KOSEIDO CO LTD
REGD NAME: KK Oishi Koseido
MAIN OFFICE: 1-933 Honmachi
Tosu City Saga-Pref 841-0037 JAPAN
Tel: 0942-83-2019 Fax: 0942-85-3047
*.. The is its Mfg Factory
URL: http://www.o-koseido.co.jp
E-Mail address: (thru the URL)
Mfg of
pharmaceuticals (poultice), other
Tokyo, Osaka
Tosu City (as
given)
RYOUJI NONAKA,
PRES Koji Oishi, rep dir
Akira Oishi, v
pres Kazuyuki
Ishikawa, dir
Ken’ichi Itoh, dir
Yen Amount: In million Yen, unless otherwise stated
FINANCES FAIR A/SALES Yen 7,245 M
PAYMENTSNO COMPLAINTS CAPITAL Yen 30 M
TREND UP WORTH Yen 3,694 M
STARTED 1950 EMPLOYES 160
MFR OF PHARMACEUTICALS.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD
FOR ORDINARY BUSINESS
ENGAGEMENTS.
The subject company is an old company founded 1907 and was incorporated
in 1950. This is a specialized mfr of
pharmaceuticals, mainly poultice and the related, other. Goods are exported. Clients include pharmaceutical mfrs,
hospitals, drug stores, other.
The sales volume for Aug /2014 fiscal term amounted to Yen 7,245
million, a 27% up from
Yen 5,713 million in the previous term.
The recurring profit was posted at Yen 190 million and the net profit at
Yen 85 million, respectively, compared with Yen 224 million recurring profit
and Yen 143 million net profit, respectively, a year ago.
For the term that ended Aug 2015 the recurring profit was projected at
Yen 210 million and the net profit at Yen 95 million, respectively, on a 10%
rise in turnover, to Yen 7,950 million.
Final results are yet to be released.
The financial situation is considered FAIR and good for ORDINARY
business engagements.
Date Registered: Mar 1950
Regd No.:
3000-01-006138
(Saga-Tosu)
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 2.4 million shares
Issued: 600,000
shares
Sum: Yen 30 million
Major shareholders (%): Oishi Holdings Co Ltd* (100)
*.. Holding
company of the Group firms
Nothing
detrimental is known as to the commercial morality of executives.
Activities: Manufactures
pharmaceuticals, poultice as a main, other (--100%)
Clients: [Mfrs,
wholesalers] Kyorin Remedio Co, Teikoku Seiyaku Co, Ohki Healthcare, All Japan
Drugs, Sanko Co, other
No. of accounts:
350
Domestic areas of
activities: Nationwide
Suppliers: [Mfrs, wholesalers]
Teikoku Seiyaku Co, Kuraray Trading, Sanko Co, Mitsubishi Shoji Energy, other
Payment record: No Complaints
Location: Business area in
Tosu City, Saga-Pref. Office premises at
the caption address are owned and maintained satisfactory.
Bank References:
Bank of Saga
(Tosu)
Bank of Fukuoka
(Tosu)
Relations:
Satisfactory
(In
Million Yen)
|
Terms Ending: |
31/08/2015 |
31/08/2014 |
31/08/2013 |
31/08/2012 |
|
|
Annual
Sales |
|
7,950 |
7,245 |
5,713 |
5,065 |
|
Recur.
Profit |
|
210 |
190 |
224 |
|
|
Net
Profit |
|
95 |
85 |
143 |
30 |
|
Total
Assets |
|
|
7,680 |
7,344 |
6,388 |
|
Current
Assets |
|
|
4,645 |
4,142 |
|
|
Current
Liabs |
|
|
2,837 |
2,573 |
|
|
Net
Worth |
|
|
3,694 |
3,608 |
3,465 |
|
Capital,
Paid-Up |
|
|
30 |
30 |
30 |
|
Div.Ttl
in Million (¥) |
|
|
0.00 |
0.35 |
0.35 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
9.73 |
26.82 |
12.79 |
1.14 |
|
Current Ratio |
|
.. |
163.73 |
160.98 |
.. |
|
N.Worth Ratio |
|
.. |
48.10 |
49.13 |
54.24 |
|
R.Profit/Sales |
|
2.64 |
2.62 |
3.92 |
.. |
|
N.Profit/Sales |
|
1.19 |
1.17 |
2.50 |
0.59 |
|
Return On Equity |
|
.. |
2.30 |
3.96 |
0.87 |
Notes: Forecast
(or estimated) figures for the 31/08/2015 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.67.04 |
|
|
1 |
Rs.101.367 |
|
Euro |
1 |
Rs.73.93 |
|
YEN |
1 |
Rs.0.55 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.